Curachem Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.57M
Latest Deal Amount
  • Investors
  • 3

Curachem General Information


Provider of custom synthesis of 14C radiolabeled, 3H radiolabeled and stable-isotope labelled compounds intended to promote client satisfaction through scientific excellence, transparency, integrity and ingenuity. The company's isotope synthesis specialises in 14C and 3H non-GMP radiolabelling and stable isotope labelling and produces radiolabelled and stable isotope labelled compounds, enabling global customers to meet their requirements in order to reduce cost and increase productivity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Commercial Services
Primary Office
  • 207, Osongsaengmyeong 1-ro
  • Osong-eup, Heungdeok-gu
  • Cheongju-si, Chungcheongbuk-do 28161
  • South Korea
+82 000-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curachem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 01-Jul-2016 $8.57M 000.00 Completed Generating Revenue
1. Later Stage VC 22-Dec-2015 000 000 Completed Generating Revenue
To view Curachem’s complete valuation and funding history, request access »

Curachem Executive Team (2)

Name Title Board Seat Contact Info
Sook Shin Chief Executive Officer & President
Yun Kim Ph.D Vice President
To view Curachem’s complete executive team members history, request access »

Curachem Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Soorim Venture Capital Venture Capital Minority 000 0000 000000 0
DSC Investment Venture Capital Minority 000 0000 000000 0
Partners Investment Venture Capital Minority 000 0000 000000 0
To view Curachem’s complete investors history, request access »